CN104491469A - Longan aril-containing antrodia camphorata pharmaceutical composition capsules - Google Patents
Longan aril-containing antrodia camphorata pharmaceutical composition capsules Download PDFInfo
- Publication number
- CN104491469A CN104491469A CN201410702269.4A CN201410702269A CN104491469A CN 104491469 A CN104491469 A CN 104491469A CN 201410702269 A CN201410702269 A CN 201410702269A CN 104491469 A CN104491469 A CN 104491469A
- Authority
- CN
- China
- Prior art keywords
- parts
- antrodia camphorata
- radix
- longan aril
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001486992 Taiwanofungus camphoratus Species 0.000 title claims abstract description 29
- 240000001008 Dimocarpus longan Species 0.000 title claims abstract description 21
- 235000000235 Euphoria longan Nutrition 0.000 title claims abstract description 21
- 239000002775 capsule Substances 0.000 title claims abstract description 14
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 239000003814 drug Substances 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 6
- 206010028980 Neoplasm Diseases 0.000 abstract description 10
- 201000011510 cancer Diseases 0.000 abstract description 7
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000036039 immunity Effects 0.000 abstract description 2
- 241000173529 Aconitum napellus Species 0.000 abstract 1
- 241001633574 Adenophora stricta Species 0.000 abstract 1
- 244000248539 Asparagus cochinchinensis Species 0.000 abstract 1
- 235000009292 Asparagus cochinchinensis Nutrition 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 abstract 1
- 240000006766 Cornus mas Species 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 235000017803 cinnamon Nutrition 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 241000723347 Cinnamomum Species 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 238000009792 diffusion process Methods 0.000 description 3
- 206010003445 Ascites Diseases 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- FYGDTMLNYKFZSV-WFYNLLPOSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,3s,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-WFYNLLPOSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000123370 Antrodia Species 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 229920000018 Callose Polymers 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 241000222383 Polyporales Species 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- -1 triterpenoid compound Chemical class 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses longan aril-containing antrodia camphorata medicine pharmaceutical capsules. The longan aril-containing antrodia camphorata pharmaceutical composition capsules are composed of the following components in parts by weight: 30-50 parts of antrodia camphorate, 30-40 parts of adenophora stricta, 28-32 parts of radix polygonati officinalis, 25-30 parts of asparagus cochinchinensis, 22-26 parts of dendrobe, 20-25 parts of wolfberry, 15-20 parts of prepared rehmannia root, 12-18 parts of dogwood, 10-15 parts of moutan bark, 10-12 parts of Chinese yam, 8-12 parts of poria cocos, 8-10 parts of rhizoma alismatis, 6-9 parts of white atractylodes rhizome, 6-9 parts of longan aril, 1-2 parts of cinnamon and 1-2 parts of monkshood. The longan aril-containing antrodia camphorata pharmaceutical composition capsules disclosed by the invention have the beneficial effect of being capable of effectively inhibiting the spreading of cancer cells through experimental proof, thus greatly prolonging the patients with cancers and improving the body immunity of the patients.
Description
Technical field
The present invention relates to a kind of Antrodia Camphorata medicament composition capsule containing Arillus Longan.
Background technology
Antrodia Camphorata has another name called Antrodia camphorata, and belong to Aphyllophorales, Polyporaceae, Antrodia genus, perennial mushroom fungus class, Latin is called Antrodia camphorata, is the novel species just delivered by biochemical boundary nineteen ninety.Its growth district is between the height above sea level 450-2000 rice mountain forest of mountain area, Taiwan, the heartwood inwall that only the Cinnamomum kanahirai hay tree trunk of growth more than the peculiar a century in Taiwan is rotten, or the Cinnamomum kanahirai hay trees material moist surface of withered lodging, because it gathers not easily, add that wild Cinnamomum kanahirai hay wood is classified as national treasure level by government in recent years one of biological, also therefore illegal mining Antrodia Camphorata social events still time have what is heard.
Antrodia Camphorata except be used to prevention, treatment tumor and cancerous cell diffusion, transfer while, cancer ascites can also be eliminated, severe pain, the inappetence common to cancer sufferer in latter stage, and radiotherapy, chemotherapy side effect etc., there is the improvement effect quite shown, many cancer interviewees also represent, oneself life quality after stock cattle Antrodia camphorata obtains and significantly improves, and thus daily life gradually recovers normal.β-D-glucan(callose in Antrodia camphorata polysaccharides) there is anticancer effect, add its a large amount of triterpenoid compound composition, can anticancer effect be increased.The experiment of the large institute of platform confirms that it can suppress liver cancer cell growth.Except preventing, treat the diffusion of tumor and cancerous cell, transfer, Antrodia Camphorata can also eliminate cancer ascites, for cancer sufferer in latter stage common have an intense pain, inappetence etc., more have quite significant improvement result.
Summary of the invention
Object of the present invention is exactly for above-mentioned defect of the prior art, provides a kind of Antrodia Camphorata medicament composition capsule containing Arillus Longan.
To achieve these goals, technical scheme provided by the invention is: a kind of Antrodia Camphorata medicament composition capsule containing Arillus Longan, is made up of the following component according to parts by weight: Antrodia Camphorata 30-50 part, Radix Adenophorae (Radix Glehniae) 30-40 part, Rhizoma Polygonati Odorati 28-32 part, Radix Asparagi 25-30 part, Herba Dendrobii 22-26 part, Fructus Lycii 20-25 part, Radix Rehmanniae Preparata 15-20 part, Fructus Corni 12-18 part, Cortex Moutan 10-15 part, Rhizoma Dioscoreae 10-12 part, Poria 8-12 part, Rhizoma Alismatis 8-10 part, Rhizoma Atractylodis Macrocephalae 6-9 part, Arillus Longan 6-9 part, Cortex Cinnamomi 1-2 part, Radix Aconiti Lateralis Preparata 1-2 part.
Further, above-mentioned a kind of Antrodia Camphorata medicament composition capsule containing Arillus Longan, is made up of the following component according to parts by weight: Antrodia Camphorata 40 parts, Radix Adenophorae (Radix Glehniae) 35 parts, Rhizoma Polygonati Odorati 30 parts, Radix Asparagi 28 parts, Herba Dendrobii 24 parts, Fructus Lycii 23 parts, Radix Rehmanniae Preparata 18 parts, Fructus Corni 16 parts, Cortex Moutan 12 parts, Rhizoma Dioscoreae 11 parts, 10 parts, Poria, Rhizoma Alismatis 9 parts, the Rhizoma Atractylodis Macrocephalae 8 parts, Arillus Longan 8 parts, Cortex Cinnamomi 2 parts, Radix Aconiti Lateralis Preparata 2 parts.
Beneficial effect of the present invention is: a kind of Antrodia Camphorata medicament composition capsule containing Arillus Longan provided by the invention, the experiment proved that, can the diffusion of effective anticancer, greatly extends the survival rate of cancer patient, improves sufferer immunity of organisms.
Detailed description of the invention
embodiment 1:
An Antrodia Camphorata medicament composition capsule containing Arillus Longan, is made up of the following component according to parts by weight: Antrodia Camphorata 30-50 part, Radix Adenophorae (Radix Glehniae) 30-40 part, Rhizoma Polygonati Odorati 28-32 part, Radix Asparagi 25-30 part, Herba Dendrobii 22-26 part, Fructus Lycii 20-25 part, Radix Rehmanniae Preparata 15-20 part, Fructus Corni 12-18 part, Cortex Moutan 10-15 part, Rhizoma Dioscoreae 10-12 part, Poria 8-12 part, Rhizoma Alismatis 8-10 part, Rhizoma Atractylodis Macrocephalae 6-9 part, Arillus Longan 6-9 part, Cortex Cinnamomi 1-2 part, Radix Aconiti Lateralis Preparata 1-2 part.
embodiment 2:
An Antrodia Camphorata medicament composition capsule containing Arillus Longan, is made up of the following component according to parts by weight: Antrodia Camphorata 40 parts, Radix Adenophorae (Radix Glehniae) 35 parts, Rhizoma Polygonati Odorati 30 parts, Radix Asparagi 28 parts, Herba Dendrobii 24 parts, Fructus Lycii 23 parts, Radix Rehmanniae Preparata 18 parts, Fructus Corni 16 parts, Cortex Moutan 12 parts, Rhizoma Dioscoreae 11 parts, 10 parts, Poria, Rhizoma Alismatis 9 parts, the Rhizoma Atractylodis Macrocephalae 8 parts, Arillus Longan 8 parts, Cortex Cinnamomi 2 parts, Radix Aconiti Lateralis Preparata 2 parts.
Last it is noted that the foregoing is only the preferred embodiments of the present invention, be not limited to the present invention, although with reference to previous embodiment to invention has been detailed description, for a person skilled in the art, it still can be modified to the technical scheme described in foregoing embodiments, or carries out equivalent replacement to wherein portion of techniques feature.Within the spirit and principles in the present invention all, any amendment done, equivalent replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (2)
1. the Antrodia Camphorata medicament composition capsule containing Arillus Longan, it is characterized in that, be made up of the following component according to parts by weight: Antrodia Camphorata 30-50 part, Radix Adenophorae (Radix Glehniae) 30-40 part, Rhizoma Polygonati Odorati 28-32 part, Radix Asparagi 25-30 part, Herba Dendrobii 22-26 part, Fructus Lycii 20-25 part, Radix Rehmanniae Preparata 15-20 part, Fructus Corni 12-18 part, Cortex Moutan 10-15 part, Rhizoma Dioscoreae 10-12 part, Poria 8-12 part, Rhizoma Alismatis 8-10 part, Rhizoma Atractylodis Macrocephalae 6-9 part, Arillus Longan 6-9 part, Cortex Cinnamomi 1-2 part, Radix Aconiti Lateralis Preparata 1-2 part.
2. a kind of Antrodia Camphorata medicament composition capsule containing Arillus Longan according to claim 1, it is characterized in that, be made up of the following component according to parts by weight: Antrodia Camphorata 40 parts, Radix Adenophorae (Radix Glehniae) 35 parts, Rhizoma Polygonati Odorati 30 parts, Radix Asparagi 28 parts, Herba Dendrobii 24 parts, Fructus Lycii 23 parts, Radix Rehmanniae Preparata 18 parts, Fructus Corni 16 parts, Cortex Moutan 12 parts, Rhizoma Dioscoreae 11 parts, 10 parts, Poria, Rhizoma Alismatis 9 parts, the Rhizoma Atractylodis Macrocephalae 8 parts, Arillus Longan 8 parts, Cortex Cinnamomi 2 parts, Radix Aconiti Lateralis Preparata 2 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410702269.4A CN104491469A (en) | 2014-11-28 | 2014-11-28 | Longan aril-containing antrodia camphorata pharmaceutical composition capsules |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410702269.4A CN104491469A (en) | 2014-11-28 | 2014-11-28 | Longan aril-containing antrodia camphorata pharmaceutical composition capsules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104491469A true CN104491469A (en) | 2015-04-08 |
Family
ID=52932983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410702269.4A Pending CN104491469A (en) | 2014-11-28 | 2014-11-28 | Longan aril-containing antrodia camphorata pharmaceutical composition capsules |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104491469A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1799560A (en) * | 2005-09-28 | 2006-07-12 | 莱阳农学院 | Liver cancer resistant Antrodia camphorata and preparation method thererof |
-
2014
- 2014-11-28 CN CN201410702269.4A patent/CN104491469A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1799560A (en) * | 2005-09-28 | 2006-07-12 | 莱阳农学院 | Liver cancer resistant Antrodia camphorata and preparation method thererof |
Non-Patent Citations (2)
| Title |
|---|
| 徐光星等: "辨证治癌 扶正为先——何任治疗癌症学术经验探究(上)", 《浙江中医杂志》 * |
| 胡鸥等: "樟芝的药用保健价值及开发应用(综述)", 《亚热带植物科学》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102754721B (en) | Tetrastigma hemsleyanum Duels et Gilg tea with high contents of Tetrastigma hemsleyanum Duels et Gilg flavone, polysaccharide and kaempferol and manufacturing method of same | |
| CN102697942A (en) | Medicament capable of killing cancer cells and curing various tumors and cancers and leukemia | |
| CN111228402A (en) | Chinese herbal medicine composition for preventing and controlling African swine fever, preparation method and pig feed | |
| CN104398843A (en) | Yam-containing antrodia camphorate medicinal composition capsule | |
| CN104491469A (en) | Longan aril-containing antrodia camphorata pharmaceutical composition capsules | |
| CN104491467A (en) | Angelica sinensis-containing antrodia camphorata pharmaceutical composition capsules | |
| CN104491468A (en) | Radix ophiopogonis-containing antrodia camphorata pharmaceutical composition capsules | |
| CN104491466A (en) | Dogwood-containing antrodia camphorata pharmaceutical composition capsules | |
| CN104474290A (en) | Antrodia medicine composition capsule containing rhizoma alismatis | |
| CN104398845A (en) | Atractylodes-containing antrodia camphorate medicinal composition capsule | |
| CN104398844A (en) | Tuckahoe-containing antrodia camphorate medicinal composition capsule | |
| CN104398846A (en) | Polygonum multiflorum-containing antrodia camphorate medicinal composition capsule | |
| CN104398842A (en) | Moutan bark-containing antrodia camphorate medicinal composition capsule | |
| CN104491465A (en) | Pharmaceutical composition capsule containing Antrodia camphorat | |
| CN104474182A (en) | Antrodia and tea composition | |
| CN102836212B (en) | Hepatoprotective composition | |
| CN104435756A (en) | Pharmaceutical composition capsule containing antrodia camphorata, and preparation method therefor | |
| CN105273943A (en) | Liver-protecting healthcare liquor and preparation method thereof | |
| CN104435755A (en) | Preparation method for pharmaceutical composition capsule containing antrodia camphorata | |
| CN104472786A (en) | Preparation method of antrodia tea composition | |
| CN104431075A (en) | Antrodia camphorata and tea composition and preparation method thereof | |
| CN104171428A (en) | Feed for preventing pig flu | |
| CN104971299B (en) | Antitumor Chinese, its preparation and application | |
| CN107184926A (en) | A kind of Chinese medicine composition of auxiliary treatment gynecologic malignant tumor | |
| CN108079257A (en) | A kind of pharmaceutical composition of clinical therapy of tumor and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150408 |